Dr Amy Arnold's Outputs (3)

Developing, piloting and evaluating a Medicines Safety School Programme to be delivered by student pharmacists. (2023)
Presentation / Conference Contribution
TONNA, A.P., ARNOLD, A., BROWN, A. and DEPASQUALE, C. 2023. Developing, piloting and evaluating a Medicines Safety School Programme to be delivered by student pharmacists. Poster presented at the 2023 NES (NHS education for Scotland) annual virtual conference: collaboration for improvement, 27-28 April 2023, [virtual conference].

The aim of this research was to develop the content, pilot delivery and evaluate the effectiveness of an innovative Medicines Safety School Programme delivered by student pharmacists to primary school pupils. With the transition of healthcare to a mo... Read More about Developing, piloting and evaluating a Medicines Safety School Programme to be delivered by student pharmacists..

I really enjoyed the primary school placement and would appreciate more opportunities to interact with children: developing, piloting and evaluating a medicines safety school programme to be delivered by student pharmacists. (2022)
Presentation / Conference Contribution
TONNA, A.P., ARNOLD, A., BROWN, A., DRUMMOND, N. and DEPASQUALE, C. 2022. I really enjoyed the primary school placement and would appreciate more opportunities to interact with children: developing, piloting and evaluating a medicines safety school programme to be delivered by student pharmacists. Presented at the 2022 RGU annual learning and teaching conference (RGU LTC 2022): enhancing for impact, 21 October 2022, Aberdeen, UK.

This poster describes a project at RGU's School of Pharmacy and Life Sciences, which aimed to develop an innovative medicines safety school programme, which would be delivered by student pharmacists to an audience of primary school children.

Clinical interventions proposed by a pharmacist in the intensive care unit. (2022)
Presentation / Conference Contribution
AGIUS, R., BUTTIGIEG, M. and ARNOLD, A. 2022. Clinical interventions proposed by a pharmacist in the intensive care unit. Presented at the 50th ESCP (European Society of Clinical Pharmacy) symposium on clinical pharmacy, polypharmacy and ageing: highly individualized, interprofessional, person-centered care, 19-21 October 2022, Prague, Czech Republic.

Patients admitted to the Intensive Care Unit (ICU) are at increased risk of adverse drug events due to underlying comorbidities, organ dysfunction and pharmacokinetic alterations in addition to being prescribed almost twice as many medications as pat... Read More about Clinical interventions proposed by a pharmacist in the intensive care unit..